Q2 2025 Holdings
Filed 2025-08-14 | 55 holdings | $2.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | DEBT 1.250% 2/1 | 40131MAD1 | $256.4M | $219,454,000 | 8.8% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $195.5M | 7,316,142 | 6.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $145.9M | 1,160,425 | 5.0% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $137.8M | $140,834,000 | 4.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $112.8M | 3,605,029 | 3.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $107.2M | 194,491 | 3.7% |
| Repligen Corp | NOTE 1.000%12/1 | 759916AD1 | $100.5M | $101,000,000 | 3.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $100.0M | 727,811 | 3.4% |
| Align Technology Inc(ALGN) | COM | 016255101 | $94.0M | 496,730 | 3.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $90.2M | 2,542,104 | 3.1% |
| Irhythm Technologies Inc | NOTE 1.500% 9/0 | 450056AB2 | $90.0M | $70,000,000 | 3.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $89.7M | 1,175,876 | 3.1% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $87.1M | $101,381,000 | 3.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $85.4M | 3,283,317 | 2.9% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $78.4M | $92,740,000 | 2.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $68.3M | 5,210,831 | 2.3% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $67.8M | 522,410 | 2.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $64.2M | 1,478,512 | 2.2% |
| Glaukos Corp(GKOS) | COM | 377322102 | $62.3M | 603,414 | 2.1% |
| Danaher Corporation(DHR) | COM | 235851102 | $61.1M | 309,339 | 2.1% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $54.8M | 135,233 | 1.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $48.7M | 89,600 | 1.7% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $46.2M | 300,029 | 1.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $45.0M | 3,863,107 | 1.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $43.6M | 837,800 | 1.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $40.4M | 3,635,172 | 1.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $38.6M | 2,578,404 | 1.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $38.1M | 1,437,555 | 1.3% |
| Karyopharm Therapeutics Inc | NOTE 6.000% 5/1 | 48576UAD8 | $35.5M | $48,482,000 | 1.2% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $34.2M | 255,048 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $33.3M | 129,628 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $31.2M | 3,273,349 | 1.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $30.5M | 1,102,580 | 1.0% |
| Harrow Inc(HROW) | COM | 415858109 | $26.6M | 872,246 | 0.9% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $23.8M | 1,107,770 | 0.8% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $23.3M | $26,828,000 | 0.8% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $20.1M | 8,353,287 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $19.4M | 1,121,034 | 0.7% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $18.8M | 1,081,855 | 0.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $18.4M | 60,781 | 0.6% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $18.2M | $18,500,000 | 0.6% |
| Repligen Corp(RGEN) | COM | 759916109 | $18.0M | 144,556 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $17.1M | 1,524,842 | 0.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $16.8M | 822,735 | 0.6% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $15.4M | 49,400 | 0.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $14.6M | 247,200 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $14.2M | 2,181,598 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $13.0M | 1,655,690 | 0.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $11.8M | 884,306 | 0.4% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $5.8M | $5,818,000 | 0.2% |